Search results
Results From The WOW.Com Content Network
Amgen Inc. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5] The name "AMGen" is a portmanteau of the ...
In addition to its potent innovation engine, Amgen offers a top-tier dividend program. At current levels, the drugmaker pays an annualized yield of 2.82%, which is considerably higher than the 1. ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
June 20, 2024 at 8:15 AM. Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500 's 90% gain over that stretch. With some ...
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock ...
Amgen's ( AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a peek at phase II results of ...
In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013. During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 to $26 billion in 2021, and annual R&D investment increased to $4.2 billion in 2020.
Price Action: AMGN shares are up 0.02% at $307.38 at the last check on Wednesday. Photo via Shutterstock ... AMGEN (AMGN): Free Stock Analysis Report.